What should investors do with Sun Pharma post Q1 results: buy, sell or hold?

Sun Pharmaceutical Industries share price touched a 52-week high of Rs 799.60, rising 3 percent in the early trade on August 2 after the company reported its June quarter results.
The company on July 30 reported a net profit of Rs 1,444.1 crore in the quarter…

Click here to view the original article.